Impact of an educational intervention on the knowledge and acceptance of RSV vaccine among Thai pregnant women: a randomized controlled trial

Background Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections in infants globally. Maternal RSV vaccination is an effective preventive strategy; however, acceptance remains uncertain in many settings. This study aimed to evaluate a video-based educational intervention on willingness to accept maternal RSV vaccination among pregnant women in Thailand. Methods In a randomized controlled trial at King Chulalongkorn Memorial Hospital (December 2025 to February 2026), eligible pregnant women were randomized to receive either a 5-minute educational video on the maternal RSV vaccine plus routine antenatal care (intervention), or routine antenatal care alone (control). Questionnaires assessed vaccine acceptance, knowledge, attitudes, and barriers at baseline, immediately post-intervention, and follow-up. The primary outcome was willingness to accept maternal RSV vaccination. Secondary outcomes included changes in RSV-related knowledge and perceptions. Outcomes were compared between groups. Both outcomes were analyzed using parametric and non-parametric statistics, while the factors associated with vaccine acceptance were evaluated using multivariable logistic regression. Results Of 410 randomized participants, 383 participants completed follow-up (intervention n = 195; control n = 188). Baseline willingness to accept vaccination was similar (intervention: 67.2% vs. control: 71.8%; p = 0.33). In the intervention group, willingness increased immediately after viewing the video from 67.2% to 82.6% (increase 15.4%, 95% CI: 8.6%-23.2%). However, no significant between-group difference was observed at follow-up (78.5% vs. 77.7%; p = 0.85). The intervention group had significantly higher post-intervention knowledge scores (mean ± SD: 5.1 ± 1.3 vs. 4.7 ± 1.5; p = 0.02). Baseline acceptance, high knowledge, occupation and positive attitudes were independent predictors of willingness. Common barriers to vaccine acceptance included cost, lack of government support, and safety concerns. Conclusion A brief video intervention can improve knowledge and produce an immediate increase in willingness but did not significantly increase acceptance at follow-up. Therefore, educational interventions should be combined with strategies addressing safety concerns, provider recommendations, and financial accessibility to maximize maternal RSV vaccine uptake. Trial registration The trial was retrospectively registered with the Thai Clinical Trials Registry (Registration Number: TCTR20251226003 https://www.thaiclinicaltrials.org/show/TCTR20251226003 ). The trial was first registered on December 16, 2025, and approved on December 26, 2025. It was conducted and reported in accordance with the Consolidated Standards of Reporting Trials (CONSORT) 2025 Statement.

Authors

Publication Details

Journal
BMC Pregnancy and Childbirth
Published
2026-11-19
DOI
https://doi.org/10.1186/s12884-026-10233-x
Primary Topic
Vaccine Coverage and Hesitancy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Impact of an educational intervention on the knowledge and acceptance of RSV vaccine among Thai pregnant women: a randomized controlled trial

Surasith Chaithongwongwatthana, Nasamon Wanlapakorn, Zainab Aliyu Attahir
BMC Pregnancy and Childbirth
Vaccine Coverage and Hesitancy
article

Impact of an educational intervention on the knowledge and acceptance of RSV vaccine among Thai pregnant women: a randomized controlled trial

Surasith Chaithongwongwatthana, Nasamon Wanlapakorn, Zainab Aliyu Attahir
article en

Abstract

Background Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections in infants globally. Maternal RSV vaccination is an effective preventive strategy; however, acceptance remains uncertain in many settings. This study aimed to evaluate a video-based educational intervention on willingness to accept maternal RSV vaccination among pregnant women in Thailand. Methods In a randomized controlled trial at King Chulalongkorn Memorial Hospital (December 2025 to February 2026), eligible pregnant women were randomized to receive either a 5-minute educational video on the maternal RSV vaccine plus routine antenatal care (intervention), or routine antenatal care alone (control). Questionnaires assessed vaccine acceptance, knowledge, attitudes, and barriers at baseline, immediately post-intervention, and follow-up. The primary outcome was willingness to accept maternal RSV vaccination. Secondary outcomes included changes in RSV-related knowledge and perceptions. Outcomes were compared between groups. Both outcomes were analyzed using parametric and non-parametric statistics, while the factors associated with vaccine acceptance were evaluated using multivariable logistic regression. Results Of 410 randomized participants, 383 participants completed follow-up (intervention n = 195; control n = 188). Baseline willingness to accept vaccination was similar (intervention: 67.2% vs. control: 71.8%; p = 0.33). In the intervention group, willingness increased immediately after viewing the video from 67.2% to 82.6% (increase 15.4%, 95% CI: 8.6%-23.2%). However, no significant between-group difference was observed at follow-up (78.5% vs. 77.7%; p = 0.85). The intervention group had significantly higher post-intervention knowledge scores (mean ± SD: 5.1 ± 1.3 vs. 4.7 ± 1.5; p = 0.02). Baseline acceptance, high knowledge, occupation and positive attitudes were independent predictors of willingness. Common barriers to vaccine acceptance included cost, lack of government support, and safety concerns. Conclusion A brief video intervention can improve knowledge and produce an immediate increase in willingness but did not significantly increase acceptance at follow-up. Therefore, educational interventions should be combined with strategies addressing safety concerns, provider recommendations, and financial accessibility to maximize maternal RSV vaccine uptake. Trial registration The trial was retrospectively registered with the Thai Clinical Trials Registry (Registration Number: TCTR20251226003 https://www.thaiclinicaltrials.org/show/TCTR20251226003 ). The trial was first registered on December 16, 2025, and approved on December 26, 2025. It was conducted and reported in accordance with the Consolidated Standards of Reporting Trials (CONSORT) 2025 Statement.

BMC Pregnancy and Childbirth
Vaccine Coverage and Hesitancy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon